Baystate Wealth Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10
Closed -$1K 910
2021
Q3
$1K Hold
10
﹤0.01% 759
2021
Q2
$1K Hold
10
﹤0.01% 728
2021
Q1
$1K Hold
10
﹤0.01% 657
2020
Q4
$1K Hold
10
﹤0.01% 620
2020
Q3
$1K Hold
10
﹤0.01% 583
2020
Q2
$1K Hold
10
﹤0.01% 599
2020
Q1
$0 Hold
10
﹤0.01% 633
2019
Q4
$1K Hold
10
﹤0.01% 569
2019
Q3
$1K Hold
10
﹤0.01% 527
2019
Q2
$1K Hold
10
﹤0.01% 562
2019
Q1
$1K Hold
10
﹤0.01% 574
2018
Q4
$1K Hold
10
﹤0.01% 582
2018
Q3
$1K Hold
10
﹤0.01% 593
2018
Q2
$1K Hold
10
﹤0.01% 610
2018
Q1
$1K Hold
10
﹤0.01% 572
2017
Q4
$1K Hold
10
﹤0.01% 573
2017
Q3
$1K Hold
10
﹤0.01% 555
2017
Q2
$1K Hold
10
﹤0.01% 578
2017
Q1
$1K Buy
+10
New +$408 ﹤0.01% 540

Other funds holding HOLX

Baystate Wealth Management's HOLX Position: Q4 2021 in Review

Baystate Wealth Management sold out of Hologic (HOLX) in Q4 2021, closing a stake of 10 shares — an estimated $1K sold.

Baystate Wealth Management first reported a position in HOLX in Q1 2017 and held it in 19 quarters. The position peaked at $1K in Q3 2021. 678 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

  • Baystate Wealth Management reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
  • Baystate Wealth Management sold 10 Hologic shares in Q4 2021, an estimated $1K.
  • Baystate Wealth Management first reported a position in Hologic in Q1 2017 and held it in 19 quarters.
  • Baystate Wealth Management's Hologic position peaked at $1K in Q3 2021.
  • 678 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on Baystate Wealth Management's 13F filing for Q4 2021, filed 21 Jan 2022.